A phase III trial of GEN-003 for genital herpes
Phase of Trial: Phase III
Latest Information Update: 20 Feb 2017
At a glance
- Drugs GEN 003 (Primary)
- Indications Herpes genitalis
- Focus Therapeutic Use
- 20 Feb 2017 Planned initiation date changed to 1 Oct 2017.
- 05 Jan 2017 According to a Genocea Biosciences media release, the company anticipates to initiate this study in the fourth quarter of 2017.
- 03 Nov 2016 According to a Genocea Biosciences media release, this study is expected to begin in the second half of 2017.